šŸ’° Financial Performance

Revenue Growth by Segment

In Q2 FY26, Segment-I (Electro-Mechanical Projects) saw margin improvement to 8.8% from 8.3% YoY. Segment-II (Unitary Products) revenue de-grew 9.5% to INR 694 Cr from INR 767 Cr. Segment-III (Professional Electronics) revenue de-grew 20.1% to INR 64 Cr from INR 81 Cr.

Geographic Revenue Split

Primarily domestic (India) with significant presence in Tier 2 and Tier 3 markets. International business is scaling in the US and Europe, with trial marketing completed and supplies scaling in Q1 and Q2 FY26.

Profitability Margins

Consolidated PAT for FY25 was INR 591.28 Cr, up 42.7% from INR 414.31 Cr in FY24. Net profit margin improved as operating leverage and cost management programs took effect, with FY25 PAT margin at approximately 4.9%.

EBITDA Margin

FY25 EBITDA was INR 875.92 Cr (7.27% margin), representing a 31.7% increase from INR 664.94 Cr in FY24. The improvement is driven by a better product mix and cost-efficiency programs.

Capital Expenditure

Not explicitly disclosed as a forward-looking absolute number, but the company is investing in manufacturing facilities (ISO 45001 certified) and digitalization to support a 23.7% growth in total income recorded in FY25.

Credit Rating & Borrowing

CRISIL A1+ and CARE AA+; Stable. Fund-based bank limits of INR 665 Cr were utilized at below 10% on average, indicating very low reliance on high-cost short-term debt.

āš™ļø Operational Drivers

Raw Materials

Copper, steel, and aluminum (implied for AC/refrigeration) and crude oil derivatives (plastics/refrigerants) which represent approximately 65-70% of total manufacturing costs.

Import Sources

Sourced from domestic markets and international suppliers; specific countries include the US and Europe for specialized components and MedTech solutions.

Capacity Expansion

Operating 4 manufacturing facilities with ISO 45001 certification. Expansion is focused on localized distribution and service support to deepen penetration in Tier 2 and Tier 3 markets.

Raw Material Costs

Raw material costs are sensitive to global price volatility in crude oil and metal commodities. The company uses a cost management program to mitigate the impact of price fluctuations on the 7-8% EBIT margins.

Manufacturing Efficiency

Focus on operating leverage and a dedicated cost management program which helped improve EBIT margins in the EMP segment to 8.2% and UP segment to 8.4% in FY25.

Logistics & Distribution

Widespread network of over 4,000 channel partners and 10,000 outlets across India to support the 14% market share in the RAC business.

šŸ“ˆ Strategic Growth

Expected Growth Rate

20-25%

Growth Strategy

Achieved through deepening Tier 2/3 market penetration, scaling the US and Europe export business following successful product trials, and maintaining leadership in the commercial refrigeration and data center cooling segments.

Products & Services

Room Air Conditioners (RAC), Commercial Air Conditioning systems (Chillers, VRF, Packaged AC), Commercial Refrigeration, and MedTech solutions.

Brand Portfolio

Blue Star

New Products/Services

MedTech solutions and specialized cooling for data centers; MedTech currently faces de-growth of 20.1% due to pending regulatory policy finalization.

Market Expansion

Aggressive expansion into the US and Europe markets; US business is expected to accelerate further once the India-US trade deal is concluded.

Market Share & Ranking

Increased Room AC market share to 14% in FY25 from 10% in FY16. Largest player in the domestic commercial refrigeration business.

Strategic Alliances

Joint Ventures include Blue Star Oman Electro-Mechanical Co. LLC and Blue Star M&E Engineering Sdn Bhd (Malaysia).

šŸŒ External Factors

Industry Trends

The industry is shifting toward higher energy efficiency (BEE norms) and eco-friendly refrigerants. Blue Star is positioning itself by investing in R&D for US/Europe compliant products and digital customer experience tools.

Competitive Landscape

Facing increased competition in the cooling and refrigeration space; competing on product range, localized service, and 'way of working' to maintain a 14% RAC market share.

Competitive Moat

Brand equity and a massive distribution network (10,000+ outlets) create a high barrier to entry. Leadership in the EMP segment (7-8% margins) provides stable cash flow to fund consumer segment growth.

Macro Economic Sensitivity

Highly sensitive to monsoon patterns and summer temperatures; Q2 FY26 revenue de-grew as industry volumes fell 17% due to heavy rains.

Consumer Behavior

Shift toward deferred purchasing in anticipation of GST changes and sensitivity to energy efficiency ratings.

Geopolitical Risks

Geopolitical tensions and the use of tariff/non-tariff barriers are identified as significant concerns for the international business segment.

āš–ļø Regulatory & Governance

Industry Regulations

BEE (Bureau of Energy Efficiency) rating changes effective December 2025; MedTech business is currently constrained by pending regulatory policy frameworks.

Environmental Compliance

ISO 45001 certifications for manufacturing; focus on eco-friendly refrigerants and disposal systems to meet evolving environmental regulations.

Taxation Policy Impact

Impacted by GST rate changes; a reduction announced in August 2025 (effective Sept 22) led to deferred consumer demand in Q2 FY26.

Legal Contingencies

Uncertainties regarding the business model of the MedTech solutions business pending finalization of regulatory policy; specific case values not disclosed.

āš ļø Risk Analysis

Key Uncertainties

Weather-related demand volatility (monsoon impact) and regulatory shifts in energy labeling (BEE) which can impact margins by forcing inventory liquidation.

Geographic Concentration Risk

Heavy reliance on the Indian market, though diversifying through subsidiaries in Qatar, Oman, Malaysia, and North America.

Third Party Dependencies

Reliance on 4,000 channel partners for secondary sales; high channel inventory levels pose a risk to primary sales if secondary offtake is slow.

Technology Obsolescence Risk

Risk of changing technology in refrigerants and energy efficiency; mitigated by R&D for global markets (US/Europe).

Credit & Counterparty Risk

Strong liquidity with INR 843 Cr in cash and low bank limit utilization (<10%) suggests high quality of receivables and low credit risk.